Patent ID: 9624266
Date: 2017-04-18
CPC Classifications: A61K,C07K,C12N,C12R

Claim:
1. A composition comprising an isolated peptaibol having sequence AcAib-Asn-Aib-Leu-Aib-Pro-Aib-Asn-Leu-Pro-Ileuol, a pharmaceutically acceptable carrier or a diluent, and a preservative and/or stabilizer, wherein AcAib is acetylated α aminoisobutyric acid, Aib is α aminoisobutyric acid, Asn is Asparagine, Leu is Leucine, Pro is Proline and Ileuol is Isoleucinol, represented by structure I, said peptaibol having optimal growth inhibition in the range of >56%-100% in human cancer cell lines at a concentration ranging between 1 μM-50 μM and having IC